Health-related quality of life measurement in long-term survivors and outcome following radical radiotherapy for localized prostate cancer

Strahlentherapie und Onkologie

Volumn 180, Issue 9, 2004, Pages 582-589

  Galalae, Razvan M ^a   Loch, Tillmann ^b   Riemer, Birgit ^a   Rzehak, Peter ^c   Küchler, Thomas ^a   Kimmig, Bernhard ^a   Kovács, György ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

Conformal radiotherapy; Elective pelvic irradiation; HDR brachytherapy; Health related quality of life (HRQoL); Prostate cancer

Indexed keywords

ANDROGEN; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BEAM THERAPY; BRACHYTHERAPY; CALCULATION; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG MEGADOSE; FOLLOW UP; HORMONE INHIBITION; HUMAN; INSTRUMENT; IRRADIATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS OF VARIANCE; PELVIS LYMPH NODE; PROSTATE CANCER; QUALITY OF LIFE; RADIATION DOSE; RELIABILITY; SCORING SYSTEM; TREATMENT OUTCOME; VALIDATION PROCESS;

AGED; AGED, 80 AND OVER; BRACHYTHERAPY; DATA COLLECTION; DISEASE-FREE SURVIVAL; GERMANY; HEALTH STATUS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROSTATIC NEOPLASMS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; SURVIVORS; TREATMENT OUTCOME;

EID: 4544299349     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-004-1254-x     Document Type: Article

References (23)

1. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials of cancer. J Natl Cancer Inst 1993;85:365.
2. Biermann CW, Schulze H, Küchler T. Quality of life in urological cancer: data to develop EORTC-specific tumor modules. Qual Life Res 1995;5:399.
3. Bortz J. Statistik für Sozialwissenschaftler. Berlin-Heidelberg-New York: Springer, 1989:Kap. 7-15, 17.
4. Carmines EG, Zeller RA. Reliability and validity assessment, Sage University Paper series on quantitative applications in the social sciences, 07-017. Beverly Hills, London: SAGE Publications, 1979:11.
5. Chassagne D, Dutreix A, Ash D, et al. ICRU (International Commission on Radiation Units and Measurements) Report No 58. Dose and volume specification for reporting interstitial therapy. Washington: International Commission on Radiation Units and Measurements, 1997.
6. Fayers P, Aaronson N, Bjordal K, et al. EORTC QLQ-C30 scoring manual. EORTC Study Group on Quality of Life. Brussels: European Organization for Research and Treatment of Cancer, 1995.
7. Fayers P, Weesen S, Curran D. EORTC QLQ-C30 reference values. Brussels: EORTC Quality of Life Study Group, 1998.
8. Fossa SD. Quality of life in prostate cancer: what are the issues and how are they measured? Eur Urol 1996;29:121.
9. Galalae RM, Kovacs G, Schultze J, et al. Long-term outcome after elective irradiation of the pelvic lymphatics and local dose escalation using high-dose-rate brachytherapy for locally advanced prostate cancer. Int J Radiat Oncol Biol Phys 2002;52:81-90.
10. Geinitz H, Zimmermann F, Wedel E von, et al. Biochemical control after conformal, 3-dimensional radiotherapy of prostatic carcinoma. Strahlenther Onkol 2002;178:369-77.
11. Hollenbeck BK, Dunn RL, Wei JT, et al. Neoadjuvant hormonal therapy and older age are associated with adverse sexual health-related quality-of-life outcome after prostate brachytherapy. Urology 2002;59:480-4.
12. Küchler T, Schreiber HW. Lebensqualität in der Allgemeinchirurgie - Konzepte und praktische Möglichkeiten der Messung. Hamb Ärztebl 1989;43:246-50.
13. Landberg T, Chavaudra J, Dobbs J, et al. ICRU (International Commission on Radiation Units and Measurements) Report No 50. Prescribing, recording, and reporting photon beam therapy. Washington: International Commission on Radiation Units and Measurements, 1993.
14. Lennernas B, Holmang S, Hedelin H. High-dose rate brachytherapy of prostatic adenocarcinoma in combination with external beam radiotherapy a long-term follow-up of the first 50 patients at one center. Strahlenther Onkol 2002;178:537-41.
15. Martin T, Baltas D, Kurek R, et al. 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study. Strahlenther Onkol 2004;180:225-32.
16. McNeal JE. Zonal anatomy of the prostate. Prostate 1981;2:35.
17. Nunnally JC. Psychometric theory, 2nd edn. New York: Basic Books, 1978:229-46.
18. Osoba D. Measuring the effect of cancer on quality of life. In: Osoba D, ed. Effect of cancer on quality of life. Boca Raton: CRC Press, 1991:25-40.
19. Osoba D, Aaronson NK, Zee B, et al. Modification of the EORTC QLQ-C30 (version 2.0) based upon content validity and reliability testing in large samples of patients with cancer. Qual Life Res 1997;6:103-8.
20. Pietrow PK, Parekh DJ, Smith JA Jr, et al. Health related quality of life assessment after radical prostatectomy in men with prostate specific antigen only recurrence. J Urol 2001;166:2286-90.
21. Ringdal GI, Ringdal K. Testing the EORTC Quality of Life Questionnaire on cancer patients with heterogeneous diagnoses. Qual Life Res 1993;2:129.
22. World Health Organization. The first ten years of the World Health Organization. Geneva: WHO, 1958.
23. Zietman AL. The case for neoadjuvant androgen suppression before radiation therapy. Mol Urol 2000;4:203-8.